Entasis Therapeutics Holdings Inc. (ETTX): Price and Financial Metrics


Entasis Therapeutics Holdings Inc. (ETTX)

Today's Latest Price: $5.34 USD

0.10 (1.91%)

Updated Feb 18 8:00pm

Add ETTX to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 215 in Medical - Pharmaceuticals

See all "A" rated Strong Buy stocks

ETTX Daily Price Range
ETTX 52-Week Price Range

ETTX Stock Price Chart More Charts


ETTX Price/Volume Stats

Current price $5.34 52-week high $9.25
Prev. close $5.24 52-week low $4.24
Day low $5.29 Volume 3,900
Day high $5.40 Avg. volume 7,816
50-day MA $5.03 Dividend yield N/A
200-day MA $5.96 Market Cap 70.98M

Entasis Therapeutics Holdings Inc. (ETTX) Company Bio


Entasis Therapeutics Inc. discovers and develops antibacterials to fight diseases caused by multidrug-resistant bacteria. It offers ETX2514, a broad-spectrum and potent inhibitor of class A, C, and D beta-lactamases that has activity against Acinetobacter baumannii, a gram-negative bacterium that causes severe infections, which are associated with high mortality; ETX0914, a novel oral antibiotic for the treatment of uncomplicated gonorrhea; and a drug discovery platform that focuses on developing novel antibacterials targeting serious gram-negative infections, such as pneumonia, infections of the blood, urinary tract infections, and infections following surgery. Entasis Therapeutics Inc. has strategic development collaboration with Zai Lab Limited. The company was founded in 2015 and is based in Waltham, Massachusetts. Entasis Therapeutics Inc. operates as a subsidiary of AstraZeneca PLC.


ETTX Latest News Stream


Event/TimeNews Detail
Loading, please wait...

ETTX Latest Social Stream


Loading social stream, please wait...

View Full ETTX Social Stream

ETTX Price Returns

1-mo N/A
3-mo 9.20%
6-mo -36.95%
1-year -11.00%
3-year N/A
5-year N/A
YTD 7.44%
2019 22.11%
2018 N/A
2017 N/A
2016 N/A
2015 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.6751 seconds.